Referred to the House Committee on Energy and Commerce.
This resolution is a non-binding statement adopted by the House recognizing the behavioral health challenges faced by people with rare diseases and their families. It urges federal agencies, payors, clinicians, and community organizations to prioritize access to integrated behavioral health, peer support, workforce development, cultural competency, and clinician education. It does not create new laws, change agency authority, or require federal funding. It expresses the House's views and recommendations to guide future policy and programs.
This is a simple resolution acted on by the House only; it does not go to the Senate or the President and does not have the force of law.
This House resolution recognizes behavioral health needs of people and families affected by rare diseases and urges federal agencies and payors to prioritize integrated behavioral health.
It encourages peer support expansion, cultural competency, workforce investment, reimbursement review, continuing medical education incentives, and intersector collaboration.
The resolution is non-binding and requests agencies and stakeholders to consider these priorities.
As a nonbinding House resolution it is likely to be adopted by the House but does not create law; becoming binding statute is unlikely absent follow‑on legislation.
Relative to its intended legislative type, this House resolution is a well‑focused recognition and agenda‑setting statement that clearly defines the behavioral health concerns for the rare disease community and identifies relevant actors and policy areas for attention. It uses standard nonbinding language to encourage and urge action but does not create binding legal obligations or funding authorities.
Liberals push for funding and equity focus; conservatives worry about federal overreach.
Liberals push for funding and equity focus; conservatives worry about federal overreach.
Likely strongly supportive; views the resolution as addressing an overlooked health equity gap for rare disease patients and caregivers.
Sees integration of behavioral health, cultural competency, and workforce investment as consistent with whole‑person care and civil rights concerns.
Generally favorable but cautious; approves of the goals while emphasizing feasibility, cost, and measurable outcomes.
Wants clarity on funding, implementation, and evidence supporting proposed programs before committing resources.
Mildly supportive of recognizing patient needs but wary of federal expansion and unfunded mandates.
Prefers state, local, and private-sector solutions; skeptical about new federal incentives or regulatory pressure on payors.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
As a nonbinding House resolution it is likely to be adopted by the House but does not create law; becoming binding statute is unlikely absent follow‑on legislation.
The bill has not accumulated any surfaced votes yet.
Liberals push for funding and equity focus; conservatives worry about federal overreach.
As a nonbinding House resolution it is likely to be adopted by the House but does not create law; becoming binding statute is unlikely abse…
Relative to its intended legislative type, this House resolution is a well‑focused recognition and agenda‑setting statement that clearly defines the behavioral health concerns for the rare disease community and identifi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.